Valuation: Almirall, S.A.

Market Cap 2.26B 2.53B 2.08B 1.89B 3.53B 240B 3.59B 25.08B 9.93B 126B 9.48B 9.28B 396B P/E 2026 *
26.7x
P/E 2027 * 19.4x
Enterprise Value 2.15B 2.41B 1.99B 1.8B 3.37B 229B 3.43B 23.93B 9.47B 120B 9.05B 8.85B 378B EV / Sales 2026 *
1.75x
EV / Sales 2027 * 1.51x
Free-Float
35.04%
Yield 2026 *
1.96%
Yield 2027 * 2.03%
1 day+0.58%
1 week+3.39%
Current month-1.89%
1 month-1.33%
3 months-7.50%
6 months-18.55%
Current year-19.31%
1 week 9.9
Extreme 9.9
10.42
1 month 9.81
Extreme 9.81
10.64
Current year 9.81
Extreme 9.81
13.98
1 year 9.81
Extreme 9.81
13.98
3 years 7.85
Extreme 7.85
13.98
5 years 7.16
Extreme 7.16
13.98
10 years 7.16
Extreme 7.16
18.5
Manager TitleAgeSince
Chief Executive Officer - 01/11/2022
Director of Finance/CFO 53 30/08/2025
Chief Tech/Sci/R&D Officer - 06/07/2021
Director TitleAgeSince
Director/Board Member - 31/12/2013
Director/Board Member - 31/12/2015
Chairman - 05/05/2022
Date Insider Type Main position Quantity % Market Cap. Importance
23/06/23 Buy

Executive/Senior Manager

3,000 0.0017%
22/06/23 Buy 4,340 0.0024%
22/06/23 Buy

Executive/Senior Manager

5,000 0.0028%
Change 5-day change 1-year change 3-year change Capi.($)
+0.58%+3.39%-17.91%+16.54% 2.53B
-2.54%+1.31%+54.27%+114.96% 1,135B
-1.42%+3.23%+38.56%+74.44% 635B
+0.16%+0.08%+25.29%+95.23% 505B
-0.31%+3.09%+44.14%+64.80% 378B
-1.34%-0.47%+66.04%+41.00% 358B
-0.68%+2.65%+22.98%+50.39% 295B
-1.20%+3.04%+2.33%+22.86% 266B
-1.79%+1.57%+50.56%+59.08% 237B
-0.73%-0.10%+29.02%+99.67% 193B
Average -0.93%+2.33%+31.53%+63.90% 400.62B
Weighted average by Cap. -1.34%+2.69%+40.99%+79.71%

Financials

2026 *2027 *
Net sales 1.23B 1.37B 1.13B 1.03B 1.92B 130B 1.95B 13.64B 5.4B 68.35B 5.16B 5.05B 215B 1.35B 1.51B 1.24B 1.13B 2.11B 143B 2.15B 14.98B 5.93B 75.06B 5.66B 5.54B 237B
Net income 82.76M 92.68M 76.46M 69.29M 130M 8.8B 132M 920M 364M 4.61B 348M 340M 14.53B 113M 127M 105M 94.96M 178M 12.06B 181M 1.26B 499M 6.32B 477M 467M 19.92B
Net Debt -104M -116M -95.73M -86.75M -162M -11.02B -165M -1.15B -456M -5.77B -436M -426M -18.2B -227M -254M -210M -190M -356M -24.14B -362M -2.52B -999M -12.65B -954M -934M -39.87B
Projected Income Statement - Annual - Almirall, S.A.
Logo Almirall, S.A.
Almirall SA is a Spain-based company principally engaged in the pharmaceuticals manufacture. The Company focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents. The Company's activities are divided into four business segments: Own network, which focuses on the commercialization of pharmaceuticals through own brand names; Licenses, which sells product rights to third parties; Research and development (R&D), which is responsible for the creation of drug candidates, as well as Dermatology, which includes sale of dermatological medicines in the United States. The Company operates through numerous subsidiaries in Europe, the Americas, Africa, Asia and Australia.
Employees
2,097
Date Price Change Volume
23/10/26 €10.36 +0.58% 113,912
22/10/26 €10.30 -0.77% 85,488
21/10/26 €10.38 +0.39% 102,790
20/10/26 €10.34 +3.50% 103,440
19/10/26 €9.990 -0.30% 100,535
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Almirall, S.A.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
10.36EUR
Average target price
14.32EUR
Spread / Average Target
+38.27%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Almirall, S.A.